RT Journal Article
SR Electronic
T1 Neonatal paroxetine withdrawal syndrome
JF Archives of Disease in Childhood - Fetal and Neonatal Edition
JO Arch Dis Child Fetal Neonatal Ed
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP F134
OP F135
DO 10.1136/fn.84.2.F134
VO 84
IS 2
A1 J A Stiskal
A1 N Kulin
A1 G Koren
A1 T Ho
A1 S Ito
YR 2001
UL http://fn.bmj.com/content/84/2/F134.abstract
AB Four term neonates presented with symptoms such as jitteriness and necrotising enterocolitis after paroxetine exposure in utero. Key messagesKey messagesParoxetine withdrawal syndrome was suspected in four neonates exposed to the drug in utero at maternal doses ranging from 20 to 120 mg/dayThe symptoms and abnormalities included, but were not limited to, jitteriness, vomiting, irritability, hypoglycaemia, and necrotising enterocolitisClose observation is warranted for neonates exposed to paroxetine in utero